Finally, we cannot comment on the pathophysiological implications of our findings for patients with APL, which is characterized by a particularly severe coagulopathy and in which TF production is under direct control of the PML/RAR-alpha fusion protein. This evidence concerns the gene PML and acute promyelocytic leukemia.